Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome.
Charles ChoiDaniel MollerJulia TanCarol DouErica A PetersonNadia MedvedevJan P DutzMollie N CarruthersLuke Y C ChenPublished in: British journal of haematology (2019)